Lanford RE et al. |
Comparison of tamarins and marmosets as hosts for GBV-B infections and the effect of immunosuppression on duration of viremia. |
2003 |
Virology |
pmid:12832204
|
Franke EK and Luban J |
Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction. |
1996 |
Virology |
pmid:8806510
|
Mahalingam R et al. |
Simian varicella virus reactivation in cynomolgus monkeys. |
2007 |
Virology |
pmid:17651776
|
Goldfeld AE et al. |
Cyclosporin A and FK506 block induction of the Epstein-Barr virus lytic cycle by anti-immunoglobulin. |
1995 |
Virology |
pmid:7538254
|
MistrÃková J et al. |
Increased neoplasm development due to immunosuppressive treatment with FK-506 in BALB/C mice persistently infected with the mouse herpesvirus (MHV-72). |
1999 |
Viral Immunol. |
pmid:10532652
|
Gambarino S et al. |
Human Cytomegalovirus Impact on mir-146a Expression Levels in Kidney Transplant Patients. |
2016 |
Viral Immunol. |
pmid:27077822
|
Shen ZY et al. |
Variations in the S and P regions of the hepatitis B virus genome under immunosuppression in vitro and in vivo. |
2012 |
Viral Immunol. |
pmid:22946668
|
Mortola E et al. |
The use of two immunosuppressive drugs, cyclosporin A and tacrolimus, to inhibit virus replication and apoptosis in cells infected with feline immunodeficiency virus. |
1998 |
Vet. Res. Commun. |
pmid:10066129
|
Tanaka Y et al. |
Suppression of feline coronavirus replication in vitro by cyclosporin A. |
2012 |
Vet. Res. |
pmid:22546085
|
Kano R et al. |
Treatment of sterile panniculitis in a dog. |
2004 |
Vet. Rec. |
pmid:15134169
|
Ofri R et al. |
Clinical evaluation of pimecrolimus eye drops for treatment of canine keratoconjunctivitis sicca: a comparison with cyclosporine A. |
2009 |
Vet. J. |
pmid:17950639
|
Sestak K et al. |
Tacrolimus-FK506 induced immunosuppression in gnotobiotic piglets. |
2000 |
Vet. Immunol. Immunopathol. |
pmid:11137126
|
Marsella R et al. |
Investigation on the clinical efficacy and safety of 0.1% tacrolimus ointment (Protopic) in canine atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over study. |
2004 |
Vet. Dermatol. |
pmid:15500481
|
Mauldin EA et al. |
Proliferative and necrotizing otitis externa in four cats. |
2007 |
Vet. Dermatol. |
pmid:17845627
|
Banovic F et al. |
Tacrolimus therapy for dermal arteritis of the nasal philtrum refractory to surgery and anti-inflammatory therapy (doxycycline/niacinamide and topical fluocinolone) in a dog. |
2018 |
Vet. Dermatol. |
pmid:28990239
|
Hilton H et al. |
Evaluation of four topical preparations for the treatment of cannon hyperkeratosis in a horse. |
2008 |
Vet. Dermatol. |
pmid:19055613
|
Marsella R and Nicklin CF |
Investigation on the use of 0.3% tacrolimus lotion for canine atopic dermatitis: a pilot study. |
2002 |
Vet. Dermatol. |
pmid:12174182
|
Banovic F et al. |
Therapeutic effectiveness of calcineurin inhibitors in canine vesicular cutaneous lupus erythematosus. |
2017 |
Vet. Dermatol. |
pmid:28439997
|
Rosenkrantz WS |
Pemphigus: current therapy. |
2004 |
Vet. Dermatol. |
pmid:15030557
|
Olivry T et al. |
Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis. |
2010 |
Vet. Dermatol. |
pmid:20456716
|
Marsella R et al. |
Investigation on the effects of topical therapy with 0.1% tacrolimus ointment (Protopic) on intradermal skin test reactivity in atopic dogs. |
2004 |
Vet. Dermatol. |
pmid:15305928
|
Lehner GM and Linek M |
A case of vesicular cutaneous lupus erythematosus in a Border collie successfully treated with topical tacrolimus and nicotinamide-tetracycline. |
2013 |
Vet. Dermatol. |
pmid:24118370
|
Kelley LS et al. |
Safety and tolerability of 0.1% tacrolimus solution applied to the external ear canals of atopic beagle dogs without otitis. |
2010 |
Vet. Dermatol. |
pmid:20609208
|
Bensignor E and Olivry T |
Treatment of localized lesions of canine atopic dermatitis with tacrolimus ointment: a blinded randomized controlled trial. |
2005 |
Vet. Dermatol. |
pmid:15725106
|
Scholz FM et al. |
Focal metatarsal fistulae syndrome affecting a greyhound dog successfully treated with topical 0.1% tacrolimus ointment. |
2015 |
Vet. Dermatol. |
pmid:26216245
|
Nell B et al. |
The effect of topical pimecrolimus on keratoconjunctivitis sicca and chronic superficial keratitis in dogs: results from an exploratory study. |
2005 Jan-Feb |
Vet Ophthalmol |
pmid:15644099
|
Berdoulay A et al. |
Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca. |
2005 Jul-Aug |
Vet Ophthalmol |
pmid:16008701
|
Hafizi S et al. |
Differential effects of rapamycin, cyclosporine A, and FK506 on human coronary artery smooth muscle cell proliferation and signalling. |
2004 May-Jun |
Vascul. Pharmacol. |
pmid:15607500
|
Dissemond J et al. |
Successful treatment of stasis dermatitis with topical tacrolimus. |
2004 |
VASA |
pmid:15623206
|
Woodward RS et al. |
The long-term outcomes and costs of diabetes mellitus among renal transplant recipients: tacrolimus versus cyclosporine. |
2011 |
Value Health |
pmid:21315636
|
Christ B et al. |
Interactions of sildenafil and tacrolimus in men with erectile dysfunction after kidney transplantation. |
2001 |
Urology |
pmid:11597545
|
Harmon JD et al. |
Stuttering priapism in a liver transplant patient with toxic levels of fk506. |
1999 |
Urology |
pmid:10754131
|
Chkhotua AB et al. |
Kidney transplantation from living-unrelated donors: comparison of outcome with living-related and cadaveric transplants under current immunosuppressive protocols. |
2003 |
Urology |
pmid:14665344
|
Ebert AK et al. |
[Topical therapy of balanitis xerotica obliterans in childhood. Long-term clinical results and an overview]. |
2007 |
Urologe A |
pmid:17994212
|
|
[Tacrolimus--a new perspective in kidney transplantation]. |
1996 |
Urologe A |
pmid:9022401
|
Nomura T et al. |
Enhancement by cyclosporin A of taxol-induced apoptosis of human urinary bladder cancer cells. |
2002 |
Urol. Res. |
pmid:12086014
|
Hwang MT and Goldfarb DS |
Uric acid stones following hepatic transplantation. |
2004 |
Urol. Res. |
pmid:15565437
|
Veroux P et al. |
Severe neurotoxicity in tacrolimus-treated living kidney transplantation in two cases. |
2003 |
Urol. Int. |
pmid:14646448
|
Pichler R et al. |
De novo renal cell carcinoma in a kidney allograft with focus on contrast-enhanced ultrasound. |
2014 |
Urol. Int. |
pmid:25115614
|
Naderi GH et al. |
Tacrolimus rescue therapy for corticosteroid-resistant and polyclonal antibody-resistant kidney allograft rejections. |
2009 |
Urol J |
pmid:19241339
|
Freire A et al. |
Comparison of blood tacrolimus concentrations in liver and kidney transplant recipients using ACMIA and MEIA immunoassays. |
2008 |
Ups. J. Med. Sci. |
pmid:18521804
|
Präst I et al. |
Nerve cells in transplanted pancreatic islets: no effects of cyclosporin or tacrolimus on immediate neuronal survival. |
2001 |
Ups. J. Med. Sci. |
pmid:11888070
|
Valesky EM et al. |
[Postoperative pyoderma gangrenosum of Cullen]. |
2007 |
Unfallchirurg |
pmid:17786400
|
Deleuran M et al. |
[Topical immune modulation and risk of cancer]. |
2009 |
Ugeskr. Laeg. |
pmid:19732533
|
Rosenzweig M |
[Prescription of topical immunomodulators]. |
2009 |
Ugeskr. Laeg. |
pmid:19732534
|
Thestrup-Pedersen K and Thomsen TF |
[Creams used in the treatment of children can cause cancer]. |
2005 |
Ugeskr. Laeg. |
pmid:15832731
|
Tusgaard Petersen B et al. |
[Family occurrence of steroid-sensitive idiopathic nephrotic syndrome]. |
2012 |
Ugeskr. Laeg. |
pmid:23153469
|
Mørtz CG and Deleuran MS |
[A case of childhood granulomatous perioral dermatitis (CGPD) in a three year old boy from Madagascar]. |
2008 |
Ugeskr. Laeg. |
pmid:18252166
|
Tümgör G et al. |
Fatty liver due to high levels of serum tacrolimus after liver transplantation. |
2007 Apr-Jun |
Turk. J. Pediatr. |
pmid:17907528
|
Ismailoglu O et al. |
Topical application of tacrolimus prevents epidural fibrosis in a rat postlaminectomy model: histopathological and ultrastructural analysis. |
2011 |
Turk Neurosurg |
pmid:22194127
|
Tümgör G et al. |
A case of uneventful ABO-incompatible liver transplantation from a deceased donor managed with routine immunosuppressive treatment. |
2014 |
Turk J Gastroenterol |
pmid:25599790
|
Dinçkan A et al. |
Evaluation of the first 100 liver transplantations. |
2008 |
Turk J Gastroenterol |
pmid:18386237
|
Bajetta E et al. |
Merkel cell carcinoma after liver transplantation: a case report. |
2007 May-Jun |
Tumori |
pmid:17679476
|
Vennarecci G et al. |
[Acute liver toxicity of antiretroviral therapy (HAART) after liver transplantation in a patient with HIV-HCV coinfection and associated hepatocarcinoma (HCC)]. |
2003 Jul-Aug |
Tumori |
pmid:12903579
|
Sommerer C et al. |
Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. |
2016 |
Trials |
pmid:26888217
|
Nashan B et al. |
Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial. |
2015 |
Trials |
pmid:25873064
|
Snyder SH et al. |
Neural actions of immunophilin ligands. |
1998 |
Trends Pharmacol. Sci. |
pmid:9509898
|
Liu J |
FK506 and ciclosporin: molecular probes for studying intracellular signal transduction. |
1993 |
Trends Pharmacol. Sci. |
pmid:7692652
|
Chang JY et al. |
FK506 and rapamycin: novel pharmacological probes of the immune response. |
1991 |
Trends Pharmacol. Sci. |
pmid:1710854
|
Cardenas ME et al. |
Signal-transduction cascades as targets for therapeutic intervention by natural products. |
1998 |
Trends Biotechnol. |
pmid:9807840
|
Kunz J and Hall MN |
Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. |
1993 |
Trends Biochem. Sci. |
pmid:7694398
|
|
Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Drug levels in PHAs who receive liver transplants. |
2003 Apr-May |
TreatmentUpdate |
pmid:17216847
|
Sheiner PA et al. |
Acute renal failure associated with the use of ibuprofen in two liver transplant recipients on FK506. |
1994 |
Transplantation |
pmid:7513099
|
Troppmann C et al. |
Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: a matched-pair pilot study. |
2003 |
Transplantation |
pmid:12883205
|
Pech T et al. |
Combination therapy of tacrolimus and infliximab reduces inflammatory response and dysmotility in experimental small bowel transplantation in rats. |
2012 |
Transplantation |
pmid:22167049
|
Thomas J et al. |
The immunosuppressive action of FK506. In vitro induction of allogeneic unresponsiveness in human CTL precursors. |
1990 |
Transplantation |
pmid:1689518
|
Ellis D et al. |
Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression. |
1999 |
Transplantation |
pmid:10532541
|
Ciancio G et al. |
Randomized trial of three induction antibodies in kidney transplantation: long-term results. |
2014 |
Transplantation |
pmid:24477186
|
Molano RD et al. |
Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody. |
2003 |
Transplantation |
pmid:12811239
|
Bilolo KK et al. |
Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat. |
2003 |
Transplantation |
pmid:12811249
|
Waldman WJ et al. |
Inhibition of angiogenesis-related endothelial activity by the experimental immunosuppressive agent leflunomide. |
2001 |
Transplantation |
pmid:11707749
|
Morrissey PE et al. |
Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. |
1997 |
Transplantation |
pmid:9089224
|
Jindal RM et al. |
Effect of deoxyspergualin on the endocrine function of the rat pancreas. |
1993 |
Transplantation |
pmid:7504347
|
Millis JM et al. |
Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection. |
1996 |
Transplantation |
pmid:8629298
|
Sheiner PA et al. |
Increased risk of early rejection correlates with recovery of CD3 cell count after liver transplant in patients receiving OKT3 induction. |
1997 |
Transplantation |
pmid:9355846
|
Reding R et al. |
Conversion from cyclosporine to FK506 for salvage of immunocompromised pediatric liver allografts. Efficacy, toxicity, and dose regimen in 23 children. |
1994 |
Transplantation |
pmid:7507272
|
Storb R et al. |
FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donors. |
1993 |
Transplantation |
pmid:7692635
|
Egidi MF and Gaber AO |
Outcomes of African-American kidney-transplant recipients treated with sirolimus, tacrolimus, and corticosteroids. |
2003 |
Transplantation |
pmid:12605133
|
Osowski CL et al. |
Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients. |
1996 |
Transplantation |
pmid:8610430
|
Cassuto E et al. |
Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant: Results From OSIRIS, a French Observational Study. |
2016 |
Transplantation |
pmid:27653227
|
Saliba F et al. |
Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter Study. |
2016 |
Transplantation |
pmid:27454919
|
Jurcevic S et al. |
A new enzyme-linked immunosorbent assay to measure anti-endothelial antibodies after cardiac transplantation demonstrates greater inhibition of antibody formation by tacrolimus compared with cyclosporine. |
1998 |
Transplantation |
pmid:9603168
|
Shapiro AM et al. |
Defining optimal immunosuppression for islet transplantation based on reduced diabetogenicity in canine islet autografts. |
2002 |
Transplantation |
pmid:12490784
|
Tokita D et al. |
High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. |
2008 |
Transplantation |
pmid:18301333
|
Augustine JJ et al. |
Improved renal function after conversion from tacrolimus/sirolimus to tacrolimus/mycophenolate mofetil in kidney transplant recipients. |
2006 |
Transplantation |
pmid:16612276
|
Tan HP et al. |
Pediatric living donor kidney transplantation under alemtuzumab pretreatment and tacrolimus monotherapy: 4-year experience. |
2008 |
Transplantation |
pmid:19104412
|
Curran CF et al. |
Acute overdoses of tacrolimus. |
1996 |
Transplantation |
pmid:8932293
|
de Fijter JW |
Tacrolimus dosing in mycophenolate-treated patients--can we get away with less? |
2011 |
Transplantation |
pmid:21654351
|
Reyes J et al. |
Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection. |
2000 |
Transplantation |
pmid:10910279
|
Yamauchi A et al. |
Neurotoxicity induced by tacrolimus after liver transplantation: relation to genetic polymorphisms of the ABCB1 (MDR1) gene. |
2002 |
Transplantation |
pmid:12352921
|
Radkowski M et al. |
Detection of hepatitis C virus replication in peripheral blood mononuclear cells after orthotopic liver transplantation. |
1998 |
Transplantation |
pmid:9753352
|
Ciancio G et al. |
A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year. |
2004 |
Transplantation |
pmid:14742989
|
van Hooff JP et al. |
Tacrolimus and posttransplant diabetes mellitus in renal transplantation. |
2005 |
Transplantation |
pmid:15940032
|
Gaber AO et al. |
Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipients. |
2013 |
Transplantation |
pmid:23715050
|
Warty V et al. |
FK506: a novel immunosuppressive agent. Characteristics of binding and uptake by human lymphocytes. |
1988 |
Transplantation |
pmid:2458643
|
Ekberg H et al. |
Relationship of tacrolimus exposure and mycophenolate mofetil dose with renal function after renal transplantation. |
2011 |
Transplantation |
pmid:21562449
|
Rezeig MA et al. |
Kaposi's sarcoma in liver transplant recipients on FK506: two case reports. |
1997 |
Transplantation |
pmid:9175820
|
Foster RD et al. |
Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade. |
2003 |
Transplantation |
pmid:14508367
|
Talento A et al. |
A single administration of LFA-1 antibody confers prolonged allograft survival. |
1993 |
Transplantation |
pmid:7679531
|
Mor E et al. |
Reversal of gastrointestinal toxicity associated with long-term FK506 immunosuppression by conversion to cyclosporine in liver transplant recipients. |
1994 |
Transplantation |
pmid:7513098
|